IXC 8.33% 6.5¢ invex therapeutics ltd

Ann: Appendix 4D and Half-year Report, page-3

  1. 43 Posts.
    lightbulb Created with Sketch. 49
    Reading a little bit between the lines :

    Invex have moved to put a trademark on the reformulated exenatide
    They are looking for suppliers for a final registration study

    I'm not sure how tight the double blinding is, and whether any invex staff have taken a peek at the results (surely?)
    But if they weren't good I don't think you'd apply for a trademark for a product that doesn't work, and you also wouldn't consider future suppliers if you knew the results were negative.

    I think we're in for some good news come March
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.5¢
Change
0.005(8.33%)
Mkt cap ! $4.885M
Open High Low Value Volume
6.5¢ 6.5¢ 6.5¢ $1.02K 15.68K

Buyers (Bids)

No. Vol. Price($)
1 95743 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 7950 1
View Market Depth
Last trade - 10.07am 02/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.